A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/1994
10/25/1994	CA1332738C Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment
10/21/1994	CA2121613A1 Active compound from a sponge
10/20/1994	EP0661977A4 Treatment of colorectal cancer.
10/20/1994	CA2121296A1 Keyhole limpet hemocyanin composition with enhanced anti-tumor activity against bladder cancer
10/19/1994	EP0620004A1 Medicinal composition
10/19/1994	EP0619841A1 T-cadherin adhesion molecule
10/19/1994	EP0619742A1 Transfection of lung via aerosolized transgene delivery
10/19/1994	EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
10/19/1994	EP0619730A1 Composition of antineoplastic agents incorporated in micelles
10/19/1994	CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
10/19/1994	CN1093707A Vinyleneazaindole derivatives
10/18/1994	US5356926 Antiinflammatory agents
10/17/1994	CA2094203A1 Inhibition of angiogenesis
10/13/1994	WO1994023068A1 Method for screening for receptor agonists
10/13/1994	WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
10/13/1994	WO1994023014A1 Tumoricide t lymphocytes
10/13/1994	WO1994022915A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994	WO1994022907A1 New urea derivates, their preparation and their use
10/13/1994	WO1994022892A1 7-deazapurine modified oligonucleotides
10/13/1994	WO1994022891A1 Oligonucleotides with amide linkages replacing phosphodiester linkages
10/13/1994	WO1994022890A1 Novel 5'-substituted nucleosides and oligomers produced therefrom
10/13/1994	WO1994022888A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
10/13/1994	WO1994022867A1 Bicyclic ansamycins and their use as antitumor agents
10/13/1994	WO1994022863A1 Second messenger cell signaling inhibitors
10/13/1994	WO1994022856A1 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
10/13/1994	WO1994022849A1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation
10/13/1994	WO1994022842A1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
10/13/1994	WO1994022490A1 Conjugates of proteins and bifunctional ligands
10/13/1994	WO1994022488A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION
10/13/1994	WO1994022486A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides
10/13/1994	WO1994022466A1 Methods of using insulin-like growth factor binding proteins
10/13/1994	WO1994021240A3 Superparamagnetic particles, process for producing the same and their use
10/13/1994	CA2160154A1 Methods of using insulin-like growth factor binding proteins
10/13/1994	CA2160135A1 Method for screening for receptor agonists
10/13/1994	CA2159632A1 Novel 5'-substituted nucleosides and oligomers produced therefrom
10/13/1994	CA2159630A1 7-deazapurine modified oligonucleotides
10/13/1994	CA2159629A1 Oligonucleotides with amide linkages replacing phosphodiester linkages
10/13/1994	CA2159628A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
10/13/1994	CA2159506A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994	CA2159443A1 Lymphocyte activating agent
10/13/1994	CA2158968A1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation
10/13/1994	CA2158347A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides
10/13/1994	CA2155759A1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
10/12/1994	EP0619372A1 Tumor necrosis factor muteins
10/12/1994	EP0619315A1 Thioxanthenone antitumor agents
10/12/1994	EP0619306A1 19-Nor-vitamin D3 compounds with substituent at 2-position
10/12/1994	EP0619304A1 22-oxacholecalciferol derivative and production thereof
10/12/1994	EP0619118A1 Use of peptide derivatives
10/12/1994	EP0619117A2 Use of acemannan
10/12/1994	EP0618962A1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
10/12/1994	EP0618925A1 Gapped 2' modified oligonucleotides
10/12/1994	EP0546099B1 Use of human Interferon gamma 4-134
10/12/1994	EP0425566B1 New photosensitizing agents
10/12/1994	EP0408701B1 Macrocyclic aminophosphonic acid complexes, their preparation, formulations and use
10/12/1994	CN1093369A Phosphonooxymethyl ethers of taxane derivatives
10/12/1994	CN1093357A Novel selective aromatase inhibiting compounds
10/11/1994	US5354844 Protein-polycation conjugates
10/11/1994	US5354778 N-Phenyl-N'-substituted phenylsulfonylureas
10/11/1994	US5354754 Pyrrolopyrimidines, their production and use
10/11/1994	US5354745 Estradiol derivative-chlorambucil conjugate process for preparing the same, and pharmaceutical composition
10/11/1994	US5354683 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
10/11/1994	CA1332423C Platinum coordination compound
10/11/1994	CA1332414C Camptothecin derivatives and process for preparing same
10/06/1994	DE4410136A1 Tumoricidal T lymphocytes
10/06/1994	DE4310643A1 Cyclic adhesion inhibitors
10/05/1994	EP0618230A1 Anti-metastatic factor
10/05/1994	EP0618225A1 Linear adhesion inhibitors
10/05/1994	EP0618221A2 Heterocyclic inhibitors of farnesyl protein transferase
10/05/1994	EP0618220A1 Method for purifying interleukin-4
10/05/1994	EP0618206A1 Pharmaceutical compounds
10/05/1994	EP0617705A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them.
10/05/1994	EP0617625A1 Use of udpg as cancer therapy rescue agent
10/05/1994	EP0617623A1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
10/05/1994	EP0617614A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/05/1994	EP0482100B1 Novel vitamin d analogues
10/05/1994	EP0461245A4 Radiolabeled proteins for diagnostic or therapeutic use
10/05/1994	EP0436690B1 Extracts of the acanthospermum hispidum plant
10/05/1994	CN1093090A Cyclopeptides
10/05/1994	CN1026115C Novel S-adenosyl methionine inhibitors
10/04/1994	US5352810 Transesterification of diethylphosphonate or phosphoric triester with trimethylsilylbromide, treating with myoinositol protected at certain hydroxy groups in presence of condensing agent, removal of protecting groups
10/04/1994	US5352806 Anticarcinogenic agents
10/04/1994	US5352805 Water soluble derivatives of taxol
10/04/1994	US5352804 Isolation and structure of Halistatin 2
10/04/1994	US5352798 Process for preparing dithio-ethylanino 9A-methoxymitosanes
10/04/1994	US5352705 Dipeptide-based amide compounds; anticarcinogenic agents
10/04/1994	US5352684 Antitumor, anticarcinogenic agents
10/04/1994	US5352669 Increases host responsiveness to anti-neoplastic alkylating agents including chloroethylating agents for chemotheraputical treatment
10/04/1994	US5352667 Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
10/03/1994	CA2118985A1 Heterocyclic inhibitors of farnesyl protein transferase
10/02/1994	CA2120302A1 Linear adhesion inhibitors
09/1994
09/30/1994	CA2119089A1 Tumor necrosis factor muteins
09/29/1994	WO1994021808A1 Process for preparing cancer vaccines
09/29/1994	WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors
09/29/1994	WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
09/29/1994	WO1994021674A1 Polypeptide bombesin antagonists
09/29/1994	WO1994021651A1 Taxanes having furyl or thienyl substituted side-chain
09/29/1994	WO1994021622A1 Method for purifying taxoids
09/29/1994	WO1994021607A1 New heterocyclic compounds, their preparation and their use
09/29/1994	WO1994021288A1 Composition and method for reducing toxicity of biologically-active factors
09/29/1994	WO1994021287A1 Peptide coated dendritic cells as immunogens

1 ... 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 ... 2211